Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
Expected to strengthen Teva’s core CNS franchise, establish Teva’ s leadership in underserved movement disorders space, provide compelling new treatment options for patients in need, and enhance Teva’ s long-term revenue and earnings growth. JERUSALEM& LA JOLLA, Calif.—- Teva Pharmaceutical Industries Ltd. and Auspex Pharmaceuticals, Inc., today announced…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News